Abbott Laboratories (ABT)

49.03
0.26 0.53
NYSE : Health Care
Prev Close 49.29
Open 49.10
Day Low/High 48.73 / 49.17
52 Wk Low/High 37.38 / 51.13
Volume 1.86M
Avg Volume 6.08M
Exchange NYSE
Shares Outstanding 1.74B
Market Cap 86.54B
EPS 0.90
P/E Ratio 77.83
Div & Yield 1.06 (2.10%)

Latest News

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

Weekly Roundup

Markets see volatility as geopolitical tensions rise. We closed out one tech position and initiated another.

Weekly Roundup

Strong earnings and guidance lift markets. We drop a couple of names from the portfolio.

Weekly Roundup

Earnings help boost markets as D.C. isn't counted on for much of anything. Portfolio action (it was a busy week) includes a new position and a downgrade.

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Jim Cramer is bullish on Freeport-McMoRan, Apple Hospitality REIT, and Abbott Laboratories.

Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)

Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)

Jim Cramer says that when the markets switch abruptly, investors should take the opportunity to go bargain hunting.

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.

Weekly Roundup

Earnings help boost markets as D.C. isn't counted on for much of anything. Portfolio action (it was a busy week) includes a new position and a downgrade.

Cutting Back on Snap-On

We'll sell over half our SNA position after digesting yesterday's results.

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Jim Cramer says these market rotations are crushing good stocks that don't deserve it.

Cramer: Rotations Hit Companies That Don't Deserve It

Cramer: Rotations Hit Companies That Don't Deserve It

Case in point: Home Depot and Lowe's.

Dow Trades Lower as Home Depot Tumbles, Consumer Names Rise

Dow Trades Lower as Home Depot Tumbles, Consumer Names Rise

Stocks trade mixed.

We're Downgrading Snap-On

Despite earnings beat, company is in a 'battleground.'

Abbott Labs Reports Strong Quarter

Stock remains a strong performer in our portfolio.

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.

Stocks in Flux as Materials Slump, Consumer Names Trade Higher

Stocks in Flux as Materials Slump, Consumer Names Trade Higher

Stocks are in flux.

Wall Street Sets Up for More Records as T-Mobile Rises, Qualcomm Falls

Wall Street Sets Up for More Records as T-Mobile Rises, Qualcomm Falls

Stock futures are higher.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures are higher on Thursday.

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR

Quidel Diversifies With Alere's Triage Assets

Quidel Diversifies With Alere's Triage Assets

The Triage assets are being divested in order to secure antitrust approvals for Abbott Laboratories' purchase of Alere.

Earnings Previews: 7 Names to Report This Week

What we'll be looking for from ABT, NUE, DHR, KEY, SNA, GE and SLB.

Netflix, Microsoft Better Blow Everyone Away With Their Earnings This Week, Or Else

Netflix, Microsoft Better Blow Everyone Away With Their Earnings This Week, Or Else

The second-quarter earnings season picks up speed.

Weekly Roundup

The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.

Abbott Laboratories Is Set for Another Breakout

Abbott Laboratories Is Set for Another Breakout

Look to buy at the current market level.

Update on Abbott, TJX and Nucor

A deep dive into 3 of the 10 stocks we highlighted during yesterday's members-only call.

Abbott And Bigfoot Biomedical Announce Collaboration To Develop Breakthrough Diabetes Technologies

Abbott And Bigfoot Biomedical Announce Collaboration To Develop Breakthrough Diabetes Technologies

- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT